Waheed Nadia
Officer at OCUL
- Sold, on record
- $332k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 3, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- OCULOCULAR THERAPEUTIX, INCOfficer
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice OCULNoticeJun 2, 2025 2025
Filed to sell 13,861 shares ($112k)
Waheed Nadia, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale OCULRoutineJun 2, 2025 same day
Sold 13,861 shares at $8.05 ($112k)
Waheed Nadia, Chief Medical Officer
10b5-1 planSold 6.3% of holdings ($1.8M position)206,805 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice OCULNoticeFeb 12, 2026 +255 days
Filed to sell 7,863 shares ($71k)
Waheed Nadia, Officer
No 10b5-1 planFiling
- 4 Form 4 sale OCULRoutineFeb 12, 2026 same day
Sold 7,863 shares at $9.04 ($71k)
Waheed Nadia, Chief Medical Officer
10b5-1 planSold 2.4% of holdings ($2.9M position)318,417 shares leftFollows a Form 144Filing
- 5 Form 144 notice OCULNoticeFeb 20, 2026 +8 days
Filed to sell 3,510 shares ($27k)
Waheed Nadia, Officer
No 10b5-1 planFiling
- 6 Form 4 sale OCULRoutineFeb 20, 2026 same day
Sold 3,510 shares at $7.74 ($27k)
Waheed Nadia, Chief Medical Officer
10b5-1 planSold 1.1% of holdings ($2.5M position)314,907 shares leftFollows a Form 144Filing
- 7 Form 144 notice OCULNoticeJun 3, 2026 +103 days
Filed to sell 14,828 shares ($123k)
Waheed Nadia, Officer
No 10b5-1 plan1.9x usual sizeFiling
- 8 Form 4 sale OCULRoutineJun 3, 2026 same day
Sold 14,828 shares at $8.27 ($123k)
Waheed Nadia, Chief Medical Officer
10b5-1 planSold 4.7% of holdings ($2.6M position)300,079 shares left1.9x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5, 2026 | OCUL | Chief Medical Officer | Form 4 sale | 14,828 | $123k | 4.7% | Routine | SEC |
| Jun 3, 2026 | Jun 3, 2026 | OCUL | Officer | Form 144 notice | 14,828 | $123k | Notice | SEC | |
| Feb 20, 2026 | Feb 24, 2026 | OCUL | Chief Medical Officer | Form 4 sale | 3,510 | $27k | 1.1% | Routine | SEC |
| Feb 20, 2026 | Feb 20, 2026 | OCUL | Officer | Form 144 notice | 3,510 | $27k | Notice | SEC | |
| Feb 12, 2026 | Feb 17, 2026 | OCUL | Chief Medical Officer | Form 4 sale | 7,863 | $71k | 2.4% | Routine | SEC |
| Feb 12, 2026 | Feb 12, 2026 | OCUL | Officer | Form 144 notice | 7,863 | $71k | Notice | SEC | |
| Jun 2, 2025 | Jun 3, 2025 | OCUL | Chief Medical Officer | Form 4 sale | 13,861 | $112k | 6.3% | Routine | SEC |
| Jun 2, 2025 | Jun 2, 2025 | OCUL | Officer | Form 144 notice | 13,861 | $112k | Notice | SEC |